Curium US LLC Applies to Import Controlled Substance

Estimated reading time: 2–4 minutes

Curium US LLC has applied to become an importer of a controlled substance. This information was released by the Drug Enforcement Administration (DEA) in a notice published on January 8, 2026.

The application is for importing a substance called ecgonine. The drug code for ecgonine is 9180. Ecgonine is listed as a Schedule II controlled substance.

Curium US LLC is located at 2703 Wagner Place, Maryland Heights, Missouri 63043-3421. The company wants to import small amounts of a derivative form of ecgonine. The purpose is to use the substance for manufacturing. No other activities for this drug code are allowed under this registration.

Anyone interested in this proposed registration can send a comment or objection. Comments must be submitted electronically through the Federal eRulemaking Portal at https://www.regulations.gov. The deadline to submit comments or requests for a hearing is February 9, 2026. People who want a hearing need to send their request to the DEA at 8701 Morrissette Drive, Springfield, Virginia 22152.

The DEA will approve permit applications only if they fit the rules described in 21 U.S.C. 952(a)(2). The authorization does not allow for importing finished dosage forms, whether they are approved or not by the Food and Drug Administration (FDA), for commercial sale.

The notice was signed by Thomas Prevoznik, Deputy Assistant Administrator at the DEA.

For more information, see the notice published in the Federal Register Volume 91, Number 5, on January 8, 2026.

Legal Disclaimer

This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.